Versuchen GOLD - Frei
A Sustainable Future With Green Chemistry
Express Pharma
|February 16, 2018
Nitesh H Mehta, Co-Founder Director, Newreka Green-Synth Technologies and Krishna B Padia, Executive Director, Green ChemisTree Foundation, elaborate on the barriers to implementation and industrialisation of Green Chemistry and initiatives to overcome the same
-
Green Chemistry is now moving in a phase where most people are not asking the question “whether Green Chemistry or not?” but are asking“how can we implement Green Chemistry?” This means that relevance of Green Chemistry is no longer the question. Most stakeholders of chemical industry including industry, academic and research institutions, government and regulatory bodies, teachers and students, investors, etc. are clear that Green Chemistry is a powerful tool that can lead us to a sustainable future.
At times when, industry is grappling with shrinking margins and increasing pressure to comply to environment norms, industry has started seeing Green Chemistry as a tool that can enable them to achieve both economical and environmental competitiveness. The academic and research institutions are seeing Green Chemistry as an area for research where they can do meaningful work and contribute towards solving problems which are so relevant in today’s context. Teachers are beginning to see the relevance of teaching Green Chemistry to their students to have them be better prepared and equipped to deliver on the expectations of the industry and the society, after they are graduated. Students are beginning to see Green Chemistry as a very promising and growing field with potential to provide great career opportunities. Government and regulatory bodies have realised the role that Green Chemistry can play in improving the quality of air, water and soil for their people and for their country.
The next question which each of the above mentioned stakeholders of chemical industry is asking is – “how we can go about it or how we can accelerate the inclusion of Green Chemistry in our domain or in our area of accountability?”
Diese Geschichte stammt aus der February 16, 2018-Ausgabe von Express Pharma.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Express Pharma
Express Pharma
Speed and flexibility play a critical role in how we compete with larger global players
Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma
6 mins
January 2026
Express Pharma
Vizag rising: Shaping India's pharma future
At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth
9 mins
January 2026
Express Pharma
Future of pharma: Trends, challenges & AI
Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies
2 mins
January 2026
Express Pharma
Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments
When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.
1 mins
January 2026
Express Pharma
Can Indian biosimilars and generics restate accessibility in global underserved markets?
Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare
3 mins
January 2026
Express Pharma
The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers
As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.
6 mins
January 2026
Express Pharma
Results win customers. Leadership discipline keeps them
Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.
3 mins
January 2026
Express Pharma
INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF
India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge
8 mins
January 2026
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
January 2026
Express Pharma
Odisha's pharma pitch
The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury
5 mins
January 2026
Translate
Change font size
